₦ NGN
Language
Currency
‹ All headlines
ScienceDaily Health

Common blood pressure drug could make cancer therapy far more powerful

2 weeks ago
Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer drug olaparib, potentially expanding its benefits beyond patients with BRCA-related tumors. The combination is already being tested in human clinical trials after showing strong immune-boosting and anticancer effects in preclinical studies.
Get the EPELCON App v3.6.0
Invest, Learn & Earn on the go
Download APK
feedback Feedback